Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the ...

For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor ...

Glenmark Pharmaceuticals has launched Phytonadione injectable emulsion through its US arm, targeting anticoagulant markets.

It further said that the single-dose ampules are both bioequivalent and therapeutically equivalent to the reference listed ...

Dr Jo Ward told her 37k TikTok followers to "be careful" when taking the supplements. The doctor said: "If you take Vitamin D ...

Age and hypertension are associated with increased risks for cranial ischemic complications in GCA, while anticoagulant therapy may offer protective benefits.

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Bristol-Myers Squibb (NYSE:BMY), a global biopharmaceutical company with a market capitalization of nearly $120 billion, finds itself at a critical juncture as it navigates a complex landscape of ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, ...

“Studies have shown that healthcare utilization at the end of life is high, and patients receive aggressive medical care that ...